Jump to ContentJump to Main Navigation
Show Summary Details
More options …

Acta Parasitologica

4 Issues per year


IMPACT FACTOR 2017: 1.039
5-year IMPACT FACTOR: 1.121

CiteScore 2017: 1.17

SCImago Journal Rank (SJR) 2017: 0.641
Source Normalized Impact per Paper (SNIP) 2017: 0.738

Online
ISSN
1896-1851
See all formats and pricing
More options …
Volume 63, Issue 4

Issues

Meglumine antimoniate-induced DRESS: original case with a positive skin test

Amel Chaabane / Haifa Ben Romdhane / Hajer Ben Brahim / Nadia Ben Fredj / Zohra Chadli / Naceur A Boughattas / Mohamed Chakroun / Karim Aouam
Published Online: 2018-10-18 | DOI: https://doi.org/10.1515/ap-2018-0104

Abstract

We report a case of a 64-year-old woman treated with meglumine antimoniate (Glucantime®). On day 20, she developed fever, a pruriginous skin rash and myalgia. The blood tests showed eosinophilia and hepatic cytolysis. The clinico-biological picture improved gradually and the symptoms disappeared 4 weeks after the drug withdrawal. Six weeks later, intradermal tests to Glucantime® were performed and were positive at 48 hour-reading. This clinical picture suggests DRESS induced by meglumine antimoniate. To the best of our knowledge, only one case of meglumine antimoniate-induced DRESS has been reported in the literature and we are the first to report a case confirmed by skin tests.

Keywords: meglumine antimoniate; drug rash with eosinophilia and systemic symptoms (DRESS); skin tests

References

  • Barbaud A. 2014. Skin testing and patch testing in non-IgE-mediated drug allergy. Current Allergy and Asthma Reports,14, 442. CrossrefGoogle Scholar

  • Ben Salah A., Ben Messaoud N., Guedri E., Zaatour A., Ben Alaya N., Bettaieb J. et al. 2013. Topical paromomycin with or without gentamicin for cutaneous leishmaniasis. The New England Journal of Medicine, 368, 524–532. CrossrefGoogle Scholar

  • Brasileiro A., Martín-Ezquerra G., García-Martinez P., Pujol R.M., Giménez-Arnau A.M. 2017. Allergic reactions to meglumine antimoniate while treating cutaneous leishmaniasis. Journal of the European Academy of Dermatology and Venereology, 31, 59–60. CrossrefGoogle Scholar

  • Cordoba S., Gandolfo Cano M., Aguado M., Huerta-Brogera M., Romero A., Martinez-Moran C. et al. 2012. Delayed allergic skin reactions due to intralesional meglumine antimoniate therapy for cutaneous leishmaniasis. Allergy, 67, 1609–1611. CrossrefGoogle Scholar

  • Esfandiarpour I., Farajzadeh S., Rahnama Z., Fathabadi E.A., Heshmatkhah A. 2012. Adverse effects of intralesional meglumine antimoniate and its influence on clinical laboratory parameters in the treatment of cutaneous leishmaniasis. International Journal of Dermatology, 51, 1221. CrossrefGoogle Scholar

  • Jeddi F., Caumes E., Thellier M., Jauréguiberry S., Mazier D., Buffet P.A. 2009. Case report: Drug hypersensitivity syndrome induced by meglumine antimoniate. The American Journal Of Tropical Medicine And Hygiene, 80, 939–940Google Scholar

  • Kardaun S.H., Sidoroff A., Allanore V., Halevy S., Davidovici B.B., Mockenhaupt M., et al. 2007. Variability in the clinical pattern of cutaneous side-effects of drugs with systemic symptoms: does a DRESS syndrome really exist? The British Journal of Dermatology, 156, 609-611. CrossrefGoogle Scholar

  • Masmoudi A., Hariz W., Marrekchi S., Amouri M., Turki H. 2013. Old world cutaneous leishmaniasis: diagnosis and treatment. Journal of Dermatological Case Reports, 7, 31–41. CrossrefGoogle Scholar

  • Naranjo C.A., Busto U., Sellers E.M., Sandor P., Ruiz I., Roberts E.A., et al. 1981. A method for estimating the probability of adverse drug reactions. Clinical Pharmacology and Therapeutics, 30, 239–245Google Scholar

  • Wongkitisophon P., Chanprapaph K., Rattanakaemakorn P., Vachiramon V. 2012. Six-year retrospective review of drug reaction with eosinophilia and systemic symptoms. Acta Dermato-Venereologica, 92, 200–205. CrossrefGoogle Scholar

About the article

Received: 2017-11-23

Revised: 2018-05-19

Accepted: 2018-07-17

Published Online: 2018-10-18

Published in Print: 2018-12-19


Conflicts of interest. The authors declare no conflict of interest.


Citation Information: Acta Parasitologica, Volume 63, Issue 4, Pages 845–847, ISSN (Online) 1896-1851, ISSN (Print) 1230-2821, DOI: https://doi.org/10.1515/ap-2018-0104.

Export Citation

© 2018 W. Stefański Institute of Parasitology, PAS.Get Permission

Citing Articles

Here you can find all Crossref-listed publications in which this article is cited. If you would like to receive automatic email messages as soon as this article is cited in other publications, simply activate the “Citation Alert” on the top of this page.

[1]
Reactions Weekly, 2018, Volume 1728, Number 1, Page 230

Comments (0)

Please log in or register to comment.
Log in